Skip to product information
1 of 2

GDF-6/BMP-13 Protein, Human

GDF-6/BMP-13 Protein, Human

Catalog Number: UA040365 Brand: UA BIOSCIENCE
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Species Human
Synonyms Growth/differentiation factor 6; GDF-6; Bone morphogenetic protein 13 (BMP-13); Growth/differentiation factor 16;
Accession Q6KF10
Amino Acid Sequence

Thr336-Arg455

Expression System E.coli
Molecular Weight

15-16 kDa (Reducing)

Purity >95% by SDS-PAGE.
Endotoxin <0.1EU/μg
Conjugation Unconjugated
Tag No Tag
Physical Appearance Lyophilized Powder
Storage Buffer

4mM HCl

Reconstitution

Reconstitute at 0.1-1 mg/ml according to the size in 4mM HCl after rapid centrifugation.

Stability & Storage

·12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
·3 months, -20 to -80℃ under sterile conditions after reconstitution.
·1 week, 2 to 8℃ under sterile conditions after reconstitution.
·Please avoid repeated freeze-thaw cycles.

Reference

Nature. 1994 Apr 14;368(6472):639-43.
Development. 1999 Mar;126(6):1305-15.

Background

Growth differentiation factor 6 (GDF-6), also known as bone morphogenetic protein 13 (BMP-13), is a member of the transforming growth factor-beta (TGF-β) superfamily of cytokines that plays a critical role in skeletal development and joint maintenance. In humans, GDF-6 is expressed in various tissues, including cartilage, bone, and synovium, and is involved in regulating chondrogenesis, osteogenesis, and joint homeostasis. GDF-6 exerts its biological effects by binding to specific cell surface receptors, such as the BMP receptors, leading to the activation of downstream signaling pathways, including Smad and non-Smad pathways. Through its signaling activities, GDF-6 promotes the differentiation of mesenchymal stem cells into chondrocytes and osteoblasts, as well as the maintenance of cartilage integrity and joint function. GDF-6 is considered a key regulator of skeletal development and joint health, with implications for musculoskeletal disorders and regenerative medicine.

Picture

Bioactivity

Determined by its ability to induce alkaline phosphatase production by ATDC-5 cells. The expected ED50 for this effect is 2.1-2.8 ug/ml.

SDS-PAGE

2μg (R: reducing condition, N: non-reducing condition).